FDA reverses course on RTO order after layoffs and resignations threaten basic operations

FDA reverses course on RTO order after layoffs and resignations threaten basic operations

Like approving new medicines

FDA reverses course on telework after layoffs and resignations threaten basic operations - The Morning Sun

WASHINGTON (AP) — Weeks after ordering Food and Drug Administration employees back into the office, the agency is reversing course, allowing some of its most prized staffers to work remotely amid worries that recent layoffs and resignations could jeopardize basic functions, like approving new medicines. An internal email obtained by The Associated Press states that FDA leadership are “allowing review staff and supervisors to resume telework” at …

Could Kennedy's FDA cuts trigger an obscure clawback provision for industry user fees?

Last week's thousands of FDA job cuts will take a major chunk out of what the agency spends each year as part of its nearly $7 billion budget. But they could — theoretically — also have other ...

Q&A: What FDA layoffs mean for MedTech approvals

Mass layoffs at the U.S. Department of Health and Human Services (HHS), including the Food and Drug Administration (FDA), will impact the medical device regulatory process, says Ben Wolf, partner in Alston & Bird’s Health Care Group.  Wolf, an FDA attorney, sat down with MobiHealthNews to discuss how staffing cuts at the Agency could lead to longer review times for medical device approvals and his advice to streamline the process and minimize de…

Layoff Tracker: Sweeping Layoffs Across Biotech Claim Dozens of Jobs

2024 was a tough year for the biopharma industry, with several companies cutting hundreds or even thousands of employees. Follow along as BioSpace tracks job cuts and restructuring initiatives throughout 2025.